Twitter Beğeni Hilesi

We’ll be attending the Alzheimer's Association International Conference this weekend and look forward to connecting with the #Alzheimers community while delving into the latest cutting-edge advancements in #AlzheimersDisease. Learn more: bit.ly/3LxOnO7 #AAIC24

Ahead of #AAIC24 this weekend, it’s important we shed light on the prevalence of #AlzheimersDisease which drives our commitment to advance R&D. According to the Alzheimer’s Association, what is the estimated number of Americans that are living with Alzheimer’s disease?

We’re excited to be in Philadelphia for #AAIC24! We asked our Chief Medical Officer, Hideki Garren, to highlight key insights from this impactful @AlzAssociation conference.

Collaboration plays a critical role in shaping the future of #Alzheimers disease treatment options. SVP and Head of Clinical Development, Chad Swanson shares his excitement to be at #AAIC24, where research and collaboration pave the way for Alzheimer's treatment breakthroughs.

We are fueled by a deep scientific expertise built over decades of research and experience. Meet our Chief Regulatory Officer, Carol Karp and learn about the impact our regulatory team has in our shared mission to deliver innovative therapies for patients: bit.ly/4fuisf2

We’re wrapping up a productive week at #AAIC24 where we participated in many collaborative discussions with the #Alzheimers community. Thanks to Alzheimer's Association for hosting an insightful event as we strive towards advancing treatment options for patients.

Participating in #clinicaltrials is key in advancing treatment options for patients. We're enrolling participants for multiple studies for neurodegenerative & rare peripheral amyloid diseases, including #AlzheimersDisease & AL #amyloidosis. Learn more: bit.ly/3YBZygv

AL #amyloidosis is a rare, progressive disorder where amyloid deposits disrupt organ function. Hear from Chief Medical Officer, Hideki Garren, as he recently spoke with CheckRare about the latest research for this #raredisease: bit.ly/3AqScSN

This year, we proudly joined Amyloidosis's Virtual Run/Walk/Roll/Bike Event, spreading awareness in support of #amyloidosis within our local communities. Across the US and EU, our teams came together to participate in this impactful event! #RunForAmyloidosis

AL #amyloidosis can be challenging to diagnose due to its varied symptoms. Hear from those impacted by this #raredisease and the challenges they faced in putting the puzzle pieces together: bit.ly/471coHi

Explore resources from the Amyloidosis Research Consortium for insights on how #amyloidosis can impact the GI tract and potential management techniques: bit.ly/3yRvOl9

#WomensEqualityDay inspires us to reflect on how we can further empower women in our industry. Today, Prothenian Mimi DeSouza offers her insights on the critical role of workplace inclusion and its meaningful impact.

A workplace culture isn't just about productivity—it's about values. Mike Finkle shares how our commitment to fostering a positive and inclusive culture is rooted in our mission to prioritize the patient communities we serve. #ProthenaProud

The ASCENT clinical trials are now enrolling patients 55 to 85 years of age with a confirmed or suspected diagnosis of mild Alzheimer's disease or mild cognitive impairment due to Alzheimer’s disease. Learn more about how you or a loved one can participate ascent-ad.com

September is #WorldAlzMonth, a time to raise awareness and take action against the growing impact of Alzheimer's disease. With dementia cases expected to reach 139 million by 2050, we remain committed to advancing research to slow progression and prevent #Alzheimers.

Over 55 million people live with #AlzheimersDisease or other dementias, yet the misconception & stigma surrounding the condition continues. This #WorldAlzMonth, we join ADI in highlighting valuable resources for those affected by Alzheimer’s: bit.ly/46lDas8

At Prothena, we value the power of firsthand experiences. Dive into Linda's compelling journey as she advocates for awareness of #amyloidosis, offering invaluable insights into this #raredisease: bit.ly/4e0e9qB

Early diagnosis plays a crucial role in managing #Alzheimers disease, yet nearly half of those living with dementia and their care partners cite fear and stigma as major barriers to seeking a diagnosis. Learn more: bit.ly/4ddZozg